KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Vir Biotechnology (VIR) over the last 3 years, with Q3 2025 value amounting to $2.9 million.

  • Vir Biotechnology's Depreciation and Depletion changed 0.0% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 2848.1%. This contributed to the annual value of $14.2 million for FY2024, which is 2486.77% down from last year.
  • Per Vir Biotechnology's latest filing, its Depreciation and Depletion stood at $2.9 million for Q3 2025, which was down 0.0% from $2.9 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Depreciation and Depletion high stood at $5.5 million for Q1 2023, and its period low was $2.7 million during Q4 2024.
  • In the last 3 years, Vir Biotechnology's Depreciation and Depletion had a median value of $4.2 million in 2024 and averaged $3.8 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first tumbled by 3720.93% in 2024, then changed by 0.0% in 2025.
  • Over the past 3 years, Vir Biotechnology's Depreciation and Depletion (Quarter) stood at $4.3 million in 2023, then crashed by 37.21% to $2.7 million in 2024, then grew by 7.41% to $2.9 million in 2025.
  • Its Depreciation and Depletion stands at $2.9 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.8 million for Q1 2025.